U.S. Interactive Media and Services Stock News

NYSE:IONQ
NYSE:IONQTech

IonQ (IONQ) Is Up 5.7% After Surging Q1 Sales And New Quantum Commercial Launches – What's Changed

In early May 2026, IonQ reported first-quarter 2026 results showing sales of US$64.67 million versus US$7.57 million a year earlier and net income of US$805.36 million, while also advancing its quantum offering through new contracts, quantum networking projects, and the commercial launch of a millimeter-precision InSAR Earth-monitoring product. These developments underscore IonQ’s shift from primarily research-focused roots toward a broader commercial platform spanning quantum computing,...
NasdaqGS:CHRW
NasdaqGS:CHRWLogistics

A Look At C.H. Robinson (CHRW) Valuation After Amazon’s Supply Chain Push And Supreme Court Liability Risks

C.H. Robinson Worldwide (CHRW) shares came under pressure after Amazon said it would open its supply chain services to outside businesses, while a pending Supreme Court case on freight broker liability added another layer of concern. See our latest analysis for C.H. Robinson Worldwide. At a share price of $171.37, C.H. Robinson’s recent 7 day share price return of 5.74% decline and 90 day share price return of 14.57% decline point to fading momentum as investors weigh Amazon’s competitive...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

A Look At TG Therapeutics (TGTX) Valuation After Record Q1 Revenue And Higher 2026 Guidance

TG Therapeutics (TGTX) drew fresh attention after record-setting Q1 2026 revenue tied to BRIUMVI, a higher full year revenue outlook of about US$925 million, and progress on key Phase 3 clinical milestones. See our latest analysis for TG Therapeutics. The recent six day rally, with a 7 day share price return of 27.37% and a 90 day share price return of 49.08%, suggests momentum has strengthened around Q1 results, raised 2026 guidance and upcoming BRIUMVI Phase 3 readouts. The 1 year total...
NasdaqGS:GTLB
NasdaqGS:GTLBSoftware

GitLab (GTLB) Valuation Check As Claude AI Integration Deepens For Enterprise DevSecOps

GitLab (GTLB) has drawn fresh attention after expanding its integration with Anthropic’s Claude models, incorporating advanced AI agents into its existing DevSecOps governance, compliance, and audit framework for enterprise software development workflows. See our latest analysis for GitLab. At a share price of $25.92, GitLab has seen a 6.71% 1 day and 17.07% 7 day share price return. However, its year to date share price return of 28.36% and 1 year total shareholder return of 47.67% indicate...
NYSE:RBLX
NYSE:RBLXEntertainment

Roblox (RBLX) Is Down 19.0% After Cutting 2026 Outlook On New Child Safety Rules

In late April 2026, Roblox Corporation reported first-quarter sales of US$1,442 million versus US$1,035 million a year earlier, alongside a wider net loss of US$246 million and higher per-share losses. At the same time, Roblox cut its full-year outlook as new child safety and age-verification measures disrupted user engagement, even as it appointed Sunil Rao to lead expansion in India, one of its fastest-growing markets. Now we’ll examine how lowered guidance tied to friction from new...
NYSE:MPT
NYSE:MPTHealth Care REITs

A Look At Medical Properties Trust (MPT) Valuation After Its Return To Profitability In The First Quarter

Why Medical Properties Trust’s Latest Earnings Matter for Investors Medical Properties Trust (MPT) returned to profitability in the first quarter of 2026, reporting US$252.07 million in revenue and net income of US$32.83 million, after a net loss in the same period last year. See our latest analysis for Medical Properties Trust. The stronger first quarter numbers and return to profitability appear to have supported a short term rebound, with a 7 day share price return of 7.89% and 30 day...
NYSE:OWL
NYSE:OWLCapital Markets

Blue Owl Capital (OWL) Valuation After Q1 Growth, Higher Dividend, Buybacks And SpaceX Stake Sale

Blue Owl Capital (OWL) is back in focus after its first quarter update, which combined higher revenue and net income with a raised quarterly dividend, active share repurchases, and a realized gain from a partial SpaceX stake sale. See our latest analysis for Blue Owl Capital. Despite the stronger first quarter update and active capital returns, Blue Owl Capital’s recent share price performance has been mixed. A 22.2% 30 day share price return contrasts with a 32.4% share price decline year to...
NYSE:VVV
NYSE:VVVSpecialty Retail

Why Valvoline (VVV) Is Up 7.9% After Strong Q2 Results And Higher 2026 Sales Guidance

In the past week, Valvoline Inc. reported second-quarter 2026 results showing sales rising to US$503.8 million from US$403.2 million a year earlier, with net income increasing to US$44.8 million from US$37.6 million and earnings per share improving to US$0.35 from US$0.29. The company also raised its fiscal 2026 same-store sales guidance and highlighted better-than-expected contributions from the Breeze Auto Care integration, while committing US$750,000 over three years to support mental...
NYSE:KFY
NYSE:KFYProfessional Services

Korn Ferry Repeated Forbes Honor And What It May Mean For Valuation

Korn Ferry (NYSE:KFY) has been named America’s Best Executive Recruiter by Forbes Magazine for the ninth time in ten years. The recognition highlights Korn Ferry’s position among the top professional search firms in the United States. Korn Ferry’s latest recognition comes as the stock trades at $67.14, with a 3.8% return over the past year and a 51.2% return over three years. The company’s track record in executive recruitment, reflected in this recurring award, helps frame NYSE:KFY as a...
NasdaqGS:LCID
NasdaqGS:LCIDAuto

Lucid Group (LCID) Is Down 5.0% After Wider Q1 Loss and Suspended Guidance - Has The Bull Case Changed?

Lucid Group, Inc. reported first-quarter 2026 results showing sales of US$282.47 million versus US$235.05 million a year earlier, alongside a net loss of US$1.03 billion and a basic loss per share of US$3.46, both wider than the prior year. Despite ramping production and securing expanded backing from partners such as Uber and the Saudi Arabian government, Lucid’s suspended guidance, quality issues, and investigations into business practices have increased uncertainty around its operational...
NasdaqGS:CROX
NasdaqGS:CROXLuxury

Will Crocs' (CROX) Raised 2026 Outlook and Hey Dude Push Change Its Risk‑Reward Narrative?

Crocs, Inc. recently reported first-quarter 2026 results, with sales of US$921.46 million and net income of US$137.56 million, while also issuing guidance that full-year 2026 revenues could range from a 1% decline to a 1% increase versus 2025 and GAAP diluted EPS of US$12.01 to US$12.56. Despite lower year-on-year quarterly revenue and earnings, Crocs raised its full-year outlook, indicating management’s confidence while it also invests behind the Hey Dude brand’s new standalone retail...
NYSE:CAT
NYSE:CATMachinery

Should Caterpillar’s Strong Q1 Data Center Deals and Governance Debate Require Action From CAT Investors?

Caterpillar’s first-quarter 2026 results showed revenue rising to US$17,415 million and net income to US$2,549 million, alongside low double-digit full-year sales guidance, ongoing share repurchases, and new power-generation agreements linked to long-term data center and industrial demand. At the same time, a shareholder proposal on written consents and Caterpillar’s opposition to it highlight an active governance debate unfolding as the company deepens its role in powering AI-related data...
NYSE:KMT
NYSE:KMTMachinery

Why Kennametal (KMT) Is Up 7.7% After Lifting 2026 Sales Outlook And Affirming Dividend

Kennametal Inc. recently reported its fiscal 2026 third-quarter results, with sales rising to US$592.59 million and net income reaching US$58.23 million, while also raising full-year sales guidance to a range of US$2.33 billion to US$2.35 billion. Alongside the stronger earnings and upgraded outlook, the company affirmed a quarterly dividend of US$0.20 per share, highlighting management’s confidence in cash generation and balance sheet flexibility. We’ll now examine how Kennametal’s raised...
NYSE:TDG
NYSE:TDGAerospace & Defense

TransDigm Group (TDG) Is Up 7.1% After Raised 2026 Outlook And Completing $2.3B Buyback Program

In early May 2026, TransDigm Group reported past second-quarter 2026 results showing higher sales and net income year over year, completed an approximately US$798.83 million share repurchase tranche, and finished a broader buyback program totaling about US$2.32 billion for 4.75% of its shares. The company also raised its full-year 2026 guidance for net sales and earnings per share while projecting lower net income than fiscal 2025 due mainly to higher interest costs from recent...
NasdaqCM:CELC
NasdaqCM:CELCBiotechs

Celcuity’s Gedatolisib Data Sharpen Focus On Breast Cancer Commercial Path

Celcuity's lead drug candidate, gedatolisib, produced positive Phase 3 results in the VIKTORIA-1 trial for PIK3CA-mutant HR+/HER2- metastatic breast cancer. The trial met its primary endpoint and showed a significant improvement in progression-free survival. Celcuity plans to submit a supplemental NDA to the FDA, with full data scheduled for presentation at ASCO 2026. The program follows an existing Priority Review for gedatolisib in the wild-type population, with an FDA decision...
NasdaqGS:MAT
NasdaqGS:MATLeisure

Does Mattel (MAT) Now Offer Value After This Year’s 25% Share Price Slide

Wondering whether Mattel at around US$15.00 is starting to look like value, or if the stock still has more to prove before it deserves a spot in your portfolio. The share price has moved about 0.5% lower over the last 7 days, after a 4.0% gain over the last 30 days, and is currently sitting on a 25.1% decline year to date and a 13.1% decline over the last year. These moves come as investors weigh up the latest developments around the business and its position in the wider toy and...
NYSE:ALG
NYSE:ALGMachinery

Is Rising Revenue But Softer EPS Reshaping The Investment Case For Alamo Group (ALG)?

Alamo Group Inc. has released its first-quarter 2026 results, reporting sales and revenue of US$417.15 million, up from US$390.95 million a year earlier, while net income eased to US$29.18 million and diluted earnings per share from continuing operations slipped to US$2.41. The combination of higher sales but lower earnings highlights pressure on profitability, offering fresh context for how efficiently Alamo Group is converting growing demand into bottom-line results. We’ll now examine how...
NYSE:SM
NYSE:SMOil and Gas

Is SM Energy (SM) Still Attractive After Strong Year To Date Share Price Gains?

If you are wondering whether SM Energy stock still offers value at its current level, it helps to step back and separate short term noise from long term pricing signals. The share price closed at US$29.10, with returns of 52.1% year to date and 32.1% over the last year, even as the stock saw a 6.2% decline over the past week and a 7.2% decline over the last month. Recent news coverage around SM Energy has largely focused on the company within broader energy sector themes and investor...
NasdaqGS:FLNC
NasdaqGS:FLNCElectrical

Fluence Energy (FLNC) Is Up 55.7% After Record Backlog And Hyperscaler Deals - Has The Bull Case Changed?

In early May 2026, Fluence Energy, Inc. reported second-quarter revenue of US$464.89 million and a net loss of US$20.93 million, alongside a record US$5.60 billion backlog and reaffirmed full-year 2026 revenue and adjusted EBITDA guidance. The company also signed master supply agreements with two major hyperscalers, signaling growing traction in data center-related energy storage demand despite ongoing profitability challenges. We’ll now examine how the record backlog and hyperscaler...
NasdaqGS:FITB
NasdaqGS:FITBBanks

Is Fifth Third Bancorp (FITB) Price Reflecting Its Strong Multi Year Share Performance?

Wondering if Fifth Third Bancorp at around US$49.67 is offering real value or just riding sentiment? This article breaks down what the current price may be implying about the stock. The stock has recently shown mixed short term moves, with a 2.1% decline over the last 7 days, a 3.9% return over 30 days, a 4.1% return year to date, and a 38.1% return over the past year, alongside a 136.4% return over 3 years and a 42.7% return over 5 years. Recent coverage has focused on how established banks...
NasdaqGM:KDK
NasdaqGM:KDKAuto Components

Why Kodiak AI (KDK) Is Up 7.3% After $100M Raise And Defense Logistics Expansion

In early May 2026, Kodiak AI, Inc. closed a roughly US$100,000,000 private placement and reported first-quarter 2026 results showing higher sales and a move to net income, while advancing autonomous freight operations in the U.S., launching a Canadian timber pilot, and expanding into defense through a collaboration with General Dynamics Land Systems. Taken together, these moves highlight Kodiak’s push to apply its Kodiak Driver platform across long-haul trucking, industrial logistics and...
NYSE:ALL
NYSE:ALLInsurance

Is It Time To Reconsider Allstate (ALL) After Recent Insurance Sector Headwinds?

If you are wondering whether Allstate stock still offers value at its current level, the recent share performance and valuation checks provide some useful clues. The stock last closed at US$213.67, with returns of a 1.7% decline over 7 days, 1.5% over 30 days, 4.8% year to date, 7.5% over 1 year, 93.3% over 3 years, and 75.3% over 5 years. Recent news around Allstate has focused on broader industry questions such as pricing, claims costs, and the resilience of insurance balance sheets, which...
NasdaqGS:AAL
NasdaqGS:AALAirlines

Why American Airlines Group (AAL) Is Up 12.6% After Governance Shifts And Q1 Outperformance – And What's Next

American Airlines Group Inc. previously announced in its notice of the 2026 annual meeting that director Denise M. O’Leary would retire and that shareholders would vote on amending the Restated Certificate of Incorporation to limit officer liability under Delaware law, while the company urged investors to oppose proposals on cumulative voting and expanded written-consent rights. These governance moves, alongside stronger-than-expected first quarter results and plans to capture demand after...
NasdaqGS:CMPS
NasdaqGS:CMPSBiotechs

A Look At COMPASS Pathways (CMPS) Valuation After Phase 3 COMP005 Success In Treatment Resistant Depression

Investor focus on COMPASS Pathways (CMPS) has sharpened after the company reported that its Phase 3 COMP005 trial in treatment resistant depression met its primary endpoint with a statistically significant benefit over placebo. See our latest analysis for COMPASS Pathways. The Phase 3 success comes after a period of sharp share price swings, with the stock delivering a 69.49% 1 month share price return and a 43.36% year to date share price return. The 1 year total shareholder return stands at...